Health Ministry Proposes Regulatory Amendments to Oversee Antimicrobial Drugs
The Ministry of Health and Family Welfare has issued a draft gazette notification to include antimicrobials under the central regulatory framework for new drugs to combat antimicrobial resistance.
- The Ministry of Health and Family Welfare proposed amending the New Drugs and Clinical Trials Rules, 2019, via a November 6 draft gazette notification.
- Manufacturers must obtain permission from the Central Licensing Authority before applying for a manufacturing license from a State Licensing Authority.
- The amendment seeks to address antimicrobial resistance and ensure the quality, safety, and efficacy of antimicrobial products.

The Ministry of Health and Family Welfare has proposed amending the New Drugs and Clinical Trials Rules, 2019, through a draft gazette notification issued on November 6. The initiative aims to bring antimicrobials under the central regulatory framework applicable to new drugs by including them in the definition under Rule 2(1)(w)(v).
According to the ministry, antimicrobial resistance represents a significant global public health challenge that demands coordinated intervention. The action aligns with the G20 New Delhi Leaders' Declaration, which emphasized tackling the issue through a One Health approach. Officials noted that manufacturing licenses for these products have previously been granted without sufficient regulatory evaluation, such as stability and bioavailability or bioequivalence assessments.
Regulatory Approval Process and Public Consultation
Under the proposed framework, manufacturers will need to secure formal permission from the Central Licensing Authority before submitting an application for a manufacturing license to the relevant State Licensing Authority. The ministry stated that this procedural change is intended to enhance central oversight, ensuring that antimicrobial items meet proper standards for quality, safety, and efficacy while preventing the circulation of substandard products that accelerate resistance.
The draft notification remains open for public review, with the government inviting comments, objections, and suggestions from stakeholders before finalizing the amendment. Antimicrobials comprise agents that eliminate microorganisms or inhibit their proliferation, encompassing medications for treating and preventing infections alongside topical substances utilized to reduce microbial presence.
- Antimicrobials are proposed to be added under the definition of new drugs in the 2019 rules.
- The move addresses concerns over manufacturing licenses being granted without adequate scrutiny like stability and bioequivalence studies.
- Public feedback and stakeholder suggestions have been invited on the draft notification.
Spotted an error? · Our editorial policy
UP NEXTSanjay Kapoor Stars in ‘Unexpected – Safed Sach’ Based on 2024 Dehradun CaseSwipe more stories · IndiaQuick cards, a few lines each. Tap to open.More from India

Prime Minister Narendra Modi Visits IIT Kharagpur for Platinum Jubilee Celebrations

Ladakh Holds First Local Body Elections Since 2019 Reorganization

YouTuber Remanded to Prison Following Re-enactment of Madurai Jewellery Heist
